{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:39:29Z","timestamp":1793032769491,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005066","name":"Key Medical Subjects of Jiangsu Province","doi-asserted-by":"publisher","award":["BF2025638"],"award-info":[{"award-number":["BF2025638"]}],"id":[{"id":"10.13039\/501100005066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404544"],"award-info":[{"award-number":["82404544"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82571192"],"award-info":[{"award-number":["82571192"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpx.2026.100624","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:38:43Z","timestamp":1784993923000},"page":"100624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Harnessing oleic acid for facilitating topical delivery of lipid nanoparticle to the ocular posterior segment and improving anti-angiogenesis effect"],"prefix":"10.1016","volume":"12","author":[{"given":"Guihua","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sifan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoya","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100624_bb0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jconrel.2023.08.018","article-title":"Lipid-based nanocarriers challenging the ocular biological barriers: current paradigm and future perspectives","volume":"362","author":"Abla","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100624_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113992","article-title":"Innovative solid lipid nanoparticle formulations for ocular therapeutics and related patents: a systematic review","volume":"385","author":"Ahmed","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100624_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114342","article-title":"Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies","volume":"187","author":"Alshaikh","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2026.100624_bb0020","first-page":"1181","article-title":"Diffusion of high molecular weight compounds through sclera","volume":"41","author":"Ambati","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpx.2026.100624_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125099","article-title":"Development of axitinib-loaded polymeric ocular implants for the treatment of posterior ocular diseases","volume":"669","author":"Annuryanti","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100624_bb0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clae.2013.11.003","article-title":"Fluorescein staining and physiological state of corneal epithelial cells","volume":"37","author":"Bandamwar","year":"2014","journal-title":"Cont. Lens Ant. Eye"},{"key":"10.1016\/j.ijpx.2026.100624_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100773","article-title":"Scleral structure and biomechanics","volume":"74","author":"Boote","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ijpx.2026.100624_bb0040","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/d41586-025-00655-6","article-title":"How can treatment for eye disease be made easier?","volume":"639","author":"Bourzac","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ijpx.2026.100624_bb0045","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","article-title":"Targeting angiogenesis in oncology, ophthalmology and beyond","volume":"22","author":"Cao","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpx.2026.100624_bb0050","article-title":"Pharmacokinetics and ocular tolerability of of suprachoroidal CLS-AX (axitinib injectablesuspension) in rabbits","volume":"61","author":"Ciulla","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpx.2026.100624_bb0055","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41573-021-00195-4","article-title":"Kinase drug discovery 20 years after imatinib: progress and future directions","volume":"20","author":"Cohen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpx.2026.100624_bb0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10456-023-09876-7","article-title":"Pathological angiogenesis: mechanisms and therapeutic strategies","volume":"26","author":"Dudley","year":"2023","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ijpx.2026.100624_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112212","article-title":"Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases","volume":"127","author":"Fang","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijpx.2026.100624_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2024.12.075","article-title":"Nanoemulsion-based pseudopolyrotaxane hydrogel for enhanced corneal bioavailability and treatment of corneal inflammation","volume":"379","author":"Fang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100624_bb0075","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3109\/02713683.2014.904361","article-title":"Effects of oleic acid on the corneal permeability of compounds and evaluation of its ocular irritation of rabbit eyes","volume":"39","author":"Gao","year":"2014","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ijpx.2026.100624_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13091476","article-title":"Improvement of imiquimod solubilization and skin retention via TPGS micelles: exploiting the co-solubilizing effect of oleic acid","volume":"13","author":"Ghezzi","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100624_bb0085","first-page":"3815","article-title":"Phospholipid fatty acid composition of the corneal epithelium and stroma of the rabbit and human cadaver tissue","volume":"45","author":"Graff","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpx.2026.100624_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2024.109911","article-title":"Phospholipid analyses of rabbit ocular surface tissues","volume":"243","author":"Greiner","year":"2024","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpx.2026.100624_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpx.2026.100624_bb0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1208\/s12249-024-02792-z","article-title":"Silk fibroin formed bioadhesive ophthalmic gel for dry eye syndrome treatment","volume":"25","author":"Hao","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpx.2026.100624_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.107922","article-title":"Preparation and evaluation of human serum albumin-based nanoparticles for combined photothermal and chemotherapy in colorectal cancer treatment","volume":"116","author":"He","year":"2026","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100624_bb0110","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11745-001-0818-1","article-title":"Mixed-chain phospholipids: structures and chain-melting behavior","volume":"36","author":"Huang","year":"2001","journal-title":"Lipids"},{"key":"10.1016\/j.ijpx.2026.100624_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124018","article-title":"Drug-like properties of tyrosine kinase inhibitors in ophthalmology: formulation and topical availability","volume":"655","author":"Jansook","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100624_bb0120","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1021\/acs.molpharmaceut.4c00392","article-title":"On the structure, stability, and cell uptake of nanostructured lipid carriers for drug delivery","volume":"21","author":"Jeitler","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpx.2026.100624_bb0125","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1021\/acs.nanolett.9b02596","article-title":"Octopus-like flexible vector for noninvasive intraocular delivery of short interfering nucleic acids","volume":"19","author":"Jiang","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.ijpx.2026.100624_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jtos.2023.08.001","article-title":"Molecular nature of ocular surface barrier function, diseases that affect it, and its relevance for ocular drug delivery","volume":"30","author":"Kaur","year":"2023","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ijpx.2026.100624_bb0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijpharm.2019.01.036","article-title":"Vesicle-like structure of lipid-based nanoparticles as drug delivery system revealed by molecular dynamics simulations","volume":"559","author":"Khalkhali","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100624_bb0140","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1136\/bjophthalmol-2013-303513","article-title":"Non-responders to treatment with antagonists of vascular endothelial growth factor in age-related macular degeneration","volume":"97","author":"Krebs","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ijpx.2026.100624_bb0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbamem.2016.11.001","article-title":"Interaction forces and membrane charge tunability: Oleic acid containing membranes in different pH conditions","volume":"1859","author":"Kurniawan","year":"2017","journal-title":"Biochim. Biophys. Acta - Biomembr."},{"key":"10.1016\/j.ijpx.2026.100624_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104496","article-title":"Therapeutic strategies targeting ocular vasculopathies: current advances and emerging challenges","volume":"30","author":"Le Du","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijpx.2026.100624_bb0155","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/978-3-319-29346-2_26","article-title":"Challenges in ocular pharmacokinetics and drug delivery","author":"Macwan","year":"2016","journal-title":"Nano-Biomater. Ophthal. Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100624_bb0160","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41580-023-00631-w","article-title":"Biology and therapeutic targeting of vascular endothelial growth factor a","volume":"24","author":"P\u00e9rez-Guti\u00e9rrez","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijpx.2026.100624_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2019.101462","article-title":"Aqueous solubility of kinase inhibitors: I the effect of hydrophilic polymers on their \u03b3-cyclodextrin solubilization","volume":"55","author":"Praphanwittaya","year":"2020","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100624_bb0170","series-title":"Lipid Nanoparticles Traverse Non-Corneal Path to reaCh the Posterior Eye Segment: In Vivo Evidence, Molecules","author":"Puglia","year":"2021"},{"key":"10.1016\/j.ijpx.2026.100624_bb0175","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1124\/dmd.113.051193","article-title":"In vitro characterization of axitinib interactions with human efflux and hepatic uptake transporters: implications for disposition and drug interactions","volume":"41","author":"Reyner","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpx.2026.100624_bb0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2019.01.051","article-title":"Micelle-solubilized axitinib for ocular administration in anti-neovascularization","volume":"560","author":"Shi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100624_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodhyd.2023.109264","article-title":"Composite hydrogels filled with rhamnolipid-based nanoemulsion, nanostructured lipid carrier, or solid lipid nanoparticle: a comparative study on gel properties and the delivery of lutein","volume":"146","author":"Shu","year":"2024","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.ijpx.2026.100624_bb0190","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jconrel.2020.10.025","article-title":"Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery","volume":"328","author":"Singh","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100624_bb0195","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2214-109X(20)30489-7","article-title":"Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the Global Burden of Disease Study","volume":"9","author":"Steinmetz","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ijpx.2026.100624_bb0200","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jconrel.2023.07.036","article-title":"Inflammation-responsive molecular-gated contact lens for the treatment of corneal neovascularization","volume":"360","author":"Sun","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100624_bb0205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/pharmaceutics17050541","article-title":"Nanostructured lipid carrier-filled hydrogel beads for the delivery of curcumin: digestion, intestinal permeation, and antioxidant bioactivity after gastrointestinal digestion","volume":"17","author":"Sun","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100624_bb0210","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijpharm.2013.10.039","article-title":"Parenteral formulation of larotaxel lipid microsphere tackling poor solubility and chemical instability","volume":"460","author":"Teng","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100624_bb0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/jop.2021.0069","article-title":"Eyes on Lipinski\u2019s rule of five: a new \u201crule of thumb\u201d for physicochemical design space of ophthalmic drugs","volume":"38","author":"Thomas","year":"2022","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpx.2026.100624_bb0220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/17469899.2021.1902308","article-title":"Current methods and new approaches to assess aqueous humor dynamics","volume":"16","author":"Toris","year":"2021","journal-title":"Exp. Rev. Ophthalmol."},{"key":"10.1016\/j.ijpx.2026.100624_bb0225","doi-asserted-by":"crossref","first-page":"2403142","DOI":"10.1002\/adfm.202403142","article-title":"Liposome-based permeable eyedrops for effective posterior segment drug delivery","volume":"34","author":"Wang","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijpx.2026.100624_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114398","article-title":"Intraocular fate of surface charge-dependent nanomicelles via topical administration: Posterior delivery and transport pathway","volume":"388","author":"Wei","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100624_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2026.139555","article-title":"Enhancing drug distribution to ocular posterior tissues via non-invasive topical administration of nanoparticles with tuned size","volume":"735","author":"Wei","year":"2026","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.ijpx.2026.100624_bb0240","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0039-6257(01)00211-9","article-title":"The Draize Eye Test","volume":"45","author":"Wilhelmus","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ijpx.2026.100624_bb0245","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.2165\/11209230-000000000-00000","article-title":"Axitinib","volume":"72","author":"Yang","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.ijpx.2026.100624_bb0250","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrd3745","article-title":"Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma","volume":"11","author":"Zhang","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpx.2026.100624_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114574","article-title":"Non-invasive co-delivery of Axitinib and telmisartan via LDH-based nanocarriers for synergistic VEGF\/Ang-2 inhibition in ocular neovascular diseases","volume":"390","author":"Zhang","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100624_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109770","article-title":"Role of immune inflammation regulated by macrophage in the pathogenesis of age-related macular degeneration","volume":"239","author":"Zhao","year":"2024","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ijpx.2026.100624_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124702","article-title":"Elucidating acceptance and clinical indications to support the rational design of drug-eluting contact lenses","volume":"665","author":"Zhu","year":"2024","journal-title":"Int. J. Pharm."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:04:33Z","timestamp":1793030673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156726001441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":53,"alternative-id":["S2590156726001441"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100624","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing oleic acid for facilitating topical delivery of lipid nanoparticle to the ocular posterior segment and improving anti-angiogenesis effect","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100624"}}